/Equity Ratio 1.11 0.22 1.11 0.22 Leverage (Net Debt/EBITDA) 2.45 0.66 2.73 0.65
สนิต่อสว่นผู้ถือหุน้ (เท่า) 1.38 0.78 1.38 0.78 Net Debt/Equity Ratio 1.13 0.43 1.13 0.43 Leverage (Net Debt/EBITDA) 3.06 1.80 2.82 1.35
) 0% 5% 2% 7% อัตราผลตอบแทนต่อสนิทรพัยถ์าวร (ROFA) 16% 29% 20% 31% อัตราสว่นหน้ีสนิต่อสว่นผู้ถือหุน้ (เท่า) 1.61 1.38 1.61 1.38 Net Debt/Equity Ratio 1.34 1.13 1.34 1.13 Leverage (Net Debt/EBITDA) 3.60
% อัตราส่วนหน้ีสินต่อส่วนผู้ถือหุ้น (เท่า) 3.03 1.59 3.03 1.59 Net Debt/Equity Ratio 2.28 1.27 2.28 1.27 Leverage (Net Debt/EBITDA) 6.59 3.34 6.59 3.34
2017 Current Ratio (Times) 0.76 0.91 Interest-bearing Debt to Equity (Times) 2.09 1.13 LQSF Q4/2561 2560 Current Ratio (Times) 0.63 n.a. Interest-bearing Debt to Equity (Times) 0.80 n.a. Cash Flow (Unit
into any agreement which results in money borrowing; (2) if the trust may engage in debt financing, the debt-to-equity ratio shall be specified in accordance with that prescribed by the Notification of
renovation. Liquidity was maintained at healthy level with current ratio over 1, while capital structure was at optimal level with excellent ability to repay debt. 31-Dec-17 31-Dec-16 Chg Profitability ratio
borrowing from financial institutions during the period 2018. Debt-to-equity ratio improved to 2.34 at end 2018 compared to 3.35 at end of 2017. This improvement was mainly due to (1) decrease in short-term
compensation not less than the final rate 400 days. This law is effective from May 5, 2019 onwards. Such change is considered a revision of the project for the post-retirement benefit program. And has the effect
debt to equity ratio 0.35 times, shown that its sufficient liquidity and strong financial position. Please be informed accordingly, Yours Sincerely, DOD Biotech Public Company Limited (Miss Suwarin